Rong Tao Clinical Trial Pipeline: 5 Active Trials, 2 Changes This Month

5

Active Trials

5

Recruiting

1

Phase 3

3

Disease Areas

2

Changes, 30 Days

What Changed in the Last 30 Days

Detected	Trial	Change
2026-08-14	NCT07678229 BRIDGE-NK: Immunotherapy Versus Chemotherapy Induction Followed by Autologous HSCT in…	Recruitment opened
2026-08-14	NCT07727083 Clinical and Biological Cohort Study of EBV-Positive T/NK-Cell Lymphoproliferative…	Recruitment opened

New Trial Filings, Last 30 Days

First Posted	Trial	Phase	Status
2026-07-27	NCT07727083 Clinical and Biological Cohort Study of EBV-Positive T/NK-Cell Lymphoproliferative…		Recruiting

Active Trials by Phase

Phase 3

1

Phase 2

1

Phase 1/2

1

Phase 1

1

Not specified

1

Active Trials

NCT ID	Title	Condition	Status
Phase 3
NCT07678229	BRIDGE-NK: Immunotherapy Versus Chemotherapy Induction Followed by Autologous HSCT in…	Extranodal NK/T-cell Lymphoma	Recruiting
Phase 2
NCT07507318	Chidamide Maintenance for MRD-Positive Double-Expressor DLBCL in First Complete Remission	Diffuse Large B-Cell Lymphoma	Recruiting
Phase 1/2
NCT07502768	Tislelizumab Plus Zeprumetostat for Relapsed or Refractory NK/T-Cell Lymphoma	Extranodal NK/T-cell Lymphoma	Recruiting
Phase 1
NCT06445803	CD19/CD22 CAR-T Cells in Adults With R/R ALL or NHL	Acute Lymphoblastic Leukemia, in Relapse	Recruiting
Not specified
NCT07727083	Clinical and Biological Cohort Study of EBV-Positive T/NK-Cell Lymphoproliferative…	Extranodal NK/T-cell Lymphoma	Recruiting

Disease Areas

Get alerts when Rong Tao's trials change

Status changes, date slips, and new filings — detected daily, delivered to your inbox.